Works matching IS 09188959 AND DT 2021 AND VI 68 AND IP 5

Results: 11

Efficacies of programmed cell death 1 ligand 1 blockade in non-small cell lung cancer patients with acquired resistance to prior programmed cell death 1 inhibitor and development of diabetic ketoacidosis caused by two different etiologies: a retrospective case series

Published in:

Endocrine Journal, 2021, v. 68, n. 5, p. 613, doi. 10.1507/endocrj.ej20-0769

By:

Azusa Ishi;
Ichidai Tanaka;
Shintaro Iwama;
Toshihiro Sakakibara;
Toshinori Mastui;
Tomoko Kobayashi;
Tetsunari Hase;
Masahiro Morise;
Mitsuo Sato;
Hiroshi Arima;
Naozumi Hashimoto

Publication type:

Article

Primary ovarian insufficiency in a female with phosphomannomutase-2 gene (PMM2) mutations for congenital disorder of glycosylation.

Published in:

Endocrine Journal, 2021, v. 68, n. 5, p. 605, doi. 10.1507/endocrj.ej20-0706

By:

Yohei Masunaga;
Mie Mochizuki;
Machiko Kadoya;
Yoshinao Wada;
Nobuhiko Okamoto;
Maki Fukami;
Fumiko Kato;
Hirotomo Saitsu;
Tsutomu Ogata

Publication type:

Article

In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control.

Published in:

Endocrine Journal, 2021, v. 68, n. 5, p. 599, doi. 10.1507/endocrj.ej20-0620

By:

Takuya Watanabe;
Yuichi Temma;
Junichi Okada;
Eijiro Yamada;
Tsugumichi Saito;
Aya Osaki;
Yoko Shimda;
Shunichi Matsumoto;
Kazuhiko Horiguchi;
Emi Ishida;
Yuri Kondo;
Kazuya Okada;
Tetsuya Takamizawa;
Yasuyo Nakajima;
Atsushi Ozawa;
Shuichi Okada;
Mitsuaki Horigome;
Masanobu Yamada

Publication type:

Article

Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.

Published in:

Endocrine Journal, 2021, v. 68, n. 5, p. 583, doi. 10.1507/endocrj.ej20-0353

By:

DongLiang Wang;
Ying Zheng

Publication type:

Article

Application of thermography in the diagnostic investigation of thyroid nodules.

Published in:

Endocrine Journal, 2021, v. 68, n. 5, p. 573, doi. 10.1507/endocrj.ej20-0541

By:

Pereira Damião, Charbel;
Gonzalez Montero, José Ramón;
Hernandez Moran, Maira Beatriz;
Marçal e Silva Carvalho, Maria Eugênia de Oliveira;
Grotta de Farias, Camila;
Bighetti Brito, Izadora;
Nogueira Saad, Maria Auxiliadora;
Pantaleão Fontes, Cristina Asvolinsque;
Fainstein, Claudio;
Oliveira Rodrigues, Manoel Fernando;
Palombo, Aniello;
Conci, Aura;
da Cruz Filho, Rubens Antunes;
Balarini Lima, Giovanna Aparecida

Publication type:

Article

A survey of surgically resected pituitary incidentalomas and a comparison of the clinical features and surgical outcomes of non-functioning pituitary adenomas discovered incidentally versus symptomatically.

Published in:

Endocrine Journal, 2021, v. 68, n. 5, p. 561, doi. 10.1507/endocrj.ej20-0335

By:

Mayo Ono;
Izumi Fukuda;
Akimi Soga;
Shigeyuki Tahara;
Akio Morita;
Hitoshi Sugihara

Publication type:

Article

Risk perception regarding implementation of iodine thyroid blocking during a nuclear disaster of mothers living near a nuclear power station in Japan.

Published in:

Endocrine Journal, 2021, v. 68, n. 5, p. 553, doi. 10.1507/endocrj.ej20-0627

By:

Yumiko Yamada;
Makiko Orita;
Hitomi Matsunaga;
Takumi Yamaguchi;
Yasuyuki Taira;
Noboru Takamura

Publication type:

Article

Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.

Published in:

Endocrine Journal, 2021, v. 68, n. 5, p. 543, doi. 10.1507/endocrj.ej20-0453

By:

Jingjing Ma;
Zhenghua Kan

Publication type:

Article

miR-132 mediates cell permeability and migration by targeting occludin in high-glucose -induced ARPE-19 cells.

Published in:

Endocrine Journal, 2021, v. 68, n. 5, p. 531, doi. 10.1507/endocrj.ej20-0277

By:

Shan-Shan Wang;
Xing Liao;
Fei Liu;
Qian Zhang;
Jing-Jing Qiu;
Shu-Hua Fu

Publication type:

Article

Knockdown of plasmacytoma variant translocation 1 (PVT1) inhibits high glucose-induced proliferation and renal fibrosis in HRMCs by regulating miR-23b-3p/early growth response factor 1 (EGR1).

Published in:

Endocrine Journal, 2021, v. 68, n. 5, p. 519, doi. 10.1507/endocrj.ej20-0642

By:

Dongmei Yu;
Xiaohong Yang;
Yong Zhu;
Fenyan Xu;
Hong Zhang;
Zhiqiang Qiu

Publication type:

Article

An overview of thyroid function tests in subjects with resistance to thyroid hormone and related disorders.

Published in:

Endocrine Journal, 2021, v. 68, n. 5, p. 509, doi. 10.1507/endocrj.ej21-0059

By:

Tetsuya Tagami

Publication type:

Article